Literature DB >> 36069176

Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity

Karolina Dolezalova1, Tomas Strachan2, Radoslav Matej3, Dita Ricna4, Marketa Bloomfield5.   

Abstract

Background: Inborn errors of IL-12/IL-23-IFNγ immunity underlie Mendelian susceptibility to mycobacterial diseases (MSMD), a group of immunodeficiencies characterized by a highly selective susceptibility to weakly virulent strains of mycobacteria, such as non-tuberculous mycobacteria (NTM) and bacillus Calmette-Guérin (BCG). Cutaneous mycobacterial infections are common in MSMD and may represent a red flag for this immunodeficiency.
Objectives: We present a case series of four paediatric patients with MSMD, specifically with IFNγR1 and STAT1 deficiencies, and cutaneous NTM/BCG infections to increase awareness of this immunodeficiency, which may, in some cases, be intercepted by the dermatologist and thus timely referred to the immunologist. Materials &
Methods: Clinical, laboratory and genetic investigations of the four paediatric patients with MSMD are presented.
Results: All four presented patients experienced early complications after BCG vaccination. Two patients suffered recurrent mycobacteriosis, one patient experienced delayed BCG reactivation, and one patient died of disseminated avian mycobacteriosis. The dermatological manifestation in these patients included destructive nasal ulcerations, scrofuloderma of various sites and lupus vulgaris. All patients had a normal basic immune phenotype.
Conclusion: The presented cases demonstrate that NTM/BCG infections in otherwise seemingly immunocompetent patients should raise suspicion of MSMD. This is of utmost importance as specific therapeutic approaches, such as IFNγ treatment or haematopoietic stem cell transplantation, may be employed to improve the disease outcome.

Entities:  

Keywords:  MSMD; mendelian susceptibility to mycobacterial diseases; IFNγR1; STAT1; inborn error of immunity; non-tuberculous mycobacteria; BCG; necrotizing granulomas; antituberculotics

Mesh:

Substances:

Year:  2022        PMID: 36069176      PMCID: PMC9465665          DOI: 10.1684/ejd.2022.4281

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   2.805


  23 in total

1.  Clinical and histopathological features of cutaneous nontuberculous mycobacterial infection: a review of 13 cases.

Authors:  Jing Jing Li; Rohan Beresford; Janet Fyfe; Christopher Henderson
Journal:  J Cutan Pathol       Date:  2017-02-16       Impact factor: 1.587

Review 2.  Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).

Authors:  Wen-I Lee; Jing-Long Huang; Kuo-Wei Yeh; Tang-Her Jaing; Tzou-Yien Lin; Yhu-Chering Huang; Cheng-Hsun Chiu
Journal:  J Formos Med Assoc       Date:  2011-12-23       Impact factor: 3.282

Review 3.  Cutaneous Mycobacterial Infections.

Authors:  Carlos Franco-Paredes; Luis A Marcos; Andrés F Henao-Martínez; Alfonso J Rodríguez-Morales; Wilmer E Villamil-Gómez; Eduardo Gotuzzo; Alexandro Bonifaz
Journal:  Clin Microbiol Rev       Date:  2018-11-14       Impact factor: 26.132

4.  Cutaneous manifestations of infection by nontuberculous mycobacteria.

Authors:  P Escalonilla; J Esteban; M L Soriano; M C Fariña; E Piqu; R Grilli; J R Ramírez; A Barat; L Martín; L Requena
Journal:  Clin Exp Dermatol       Date:  1998-09       Impact factor: 3.470

5.  Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children.

Authors:  Jerome A Lindeboom; Ed J Kuijper; Jan M Prins; Elisabeth S Bruijnesteijn van Coppenraet; Robert Lindeboom
Journal:  Clin Infect Dis       Date:  2006-11-08       Impact factor: 9.079

Review 6.  Nontuberculous mycobacteria infections in immunosuppressed hosts.

Authors:  Emily Henkle; Kevin L Winthrop
Journal:  Clin Chest Med       Date:  2014-12-23       Impact factor: 2.878

7.  Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity.

Authors:  Rainer Döffinger; Matthew R Helbert; Gabriela Barcenas-Morales; Kun Yang; Stephanie Dupuis; Lourdes Ceron-Gutierrez; Clara Espitia-Pinzon; Neil Barnes; Graham Bothamley; Jean-Laurent Casanova; Hilary J Longhurst; Dinakantha S Kumararatne
Journal:  Clin Infect Dis       Date:  2003-12-04       Impact factor: 9.079

8.  Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population-based study.

Authors:  Ashley B Wentworth; Lisa A Drage; Nancy L Wengenack; John W Wilson; Christine M Lohse
Journal:  Mayo Clin Proc       Date:  2012-12-04       Impact factor: 7.616

9.  Granuloma with langhans giant cells: An overview.

Authors:  S Nalin Kumar; T Srinivasa Prasad; P Anantha Narayan; J Muruganandhan
Journal:  J Oral Maxillofac Pathol       Date:  2013-09

Review 10.  Treatment of Extrapulmonary Nontuberculous Mycobacterial Diseases.

Authors:  Yu Mi Wi
Journal:  Infect Chemother       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.